Arca
Skip to content

Colon cancer

Drug research and approvals for colon cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 1,194 studies of colon cancer are recruiting on ClinicalTrials.gov, Health Canada has authorized 7 drug trials for it since 2013, and the EU has 5 authorised medicines for it.

  • Recruiting worldwide: 1,194
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 5

Recruiting Now

Newest start dates first, of 1,194 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
May 31, 2023A phase 3, open-label, randomized study of perioperative dostarlimab monotherapy versus standard of care in participants with untreated t4n0 or stage iii…JEMPERLIGSKOngoing
May 3, 2023Colon adjuvant chemotherapy based on evaluation of residual disease (circulate-us)IRINOTECANCANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITYOngoing
Dec 22, 2020Circulating tumor dna analysis informing adjuvant chemotherapy in stage iii colon cancer: a multicentre phase II/iii randomised controlled study (dynamic iii)IRINOTECANCANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITYOngoing
Apr 1, 2020Phase II/iii study of circulating tumor dna as a predictive marker for response to adjuvant chemotherapy in patients with stage ii colon cancerOXALIPLATINCANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITYOngoing
Jan 8, 2019Lymphatic mapping for colon cancer using indocyanine green fluorescence imagingINDOCYANINE GREENMCGILL UNIVERSITY HEALTH CENTREPending
May 2, 2017A phase III, randomised, international trial comparing mfolfirinox triplet chemotherapy to mfolfox for high-risk stage iii colon cancer in adjuvant settingIRINOTECANCANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITYOngoing
Mar 24, 2014A phase 2 clinical trial of nivolumab and nivolumab plus ipilimumab in recurrent and metastatic microsatellite high (msi-h) colon cancer (checkmate 142:…NIVOLUMAB / IPILIMUMAB / [18F]-FLUORODEOXYGLUCOSEBristol-Myers SquibbOngoing

Medicines Authorised in the EU

Newest first

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.